MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • MDS Virtual Congress 2021

    The main reasons for essential blepharospasm botulinum neurotoxin (BoNT) treatment discontinuation in Latvian population.

    K. Lazdovska, R. Valante (Riga, Latvia)

    Objective: To investigate the effectiveness of BoNT treatment in patients with essential blepharospasm and determine the most common reasons for discontinuation of the treatment. Background: Essential…
  • MDS Virtual Congress 2021

    Spread to a third body site in patients with segmental/multifocal idiopathic adult-onset dystonia

    T. Ercoli, R. Erro, G. Fabbrini, R. Pellicciari, P. Girlanda, C. Terranova, L. Avanzino, F. Di Biasio, P. Barone, M. Esposito, G. de Joanna, R. Eleopra, F. Bono, L. Manzo, AR. Bentivoglio, M. Petracca, MM. Mascia, A. Albanese, A. Castagna, R. Ceravolo, MC. Altavista, C. Scaglione, L. Magistrelli, M. Zibetti, L. Bertolasi, M. Coletti Moja, MS. Cotelli, G. Cossu, B. Minafra, A. Pisani, S. Misceo, N. Modugno, M. Romano, D. Cassano, A. Berardelli, G. Defazio (Cagliari, Italy)

    Objective: The aim of the study is to fully characterize the spread of segmental/multifocal dystonia to a third body site in idiopathic adult-onset patients. Background: With…
  • MDS Virtual Congress 2021

    MDSGene systematic review on dopa-responsive dystonia caused by mutations in GCH1, TH, SPR, PTS, or QDPR

    A. Weissbach, R. Herzog, M. Pauly, L. Hahn, I. König, S. Camargos, B. Jeon, M. Kurian, T. Opladen, N. Brüggemann, C. Klein, K. Lohmann (Lübeck, Germany)

    Objective: To systematically review information regarding genotype, phenotype, and biochemistry in dopa-responsive dystonia (DRD). Background: To date, five causative genes (GCH1, TH, SPR, PTS, and…
  • MDS Virtual Congress 2021

    MDS Basic Scientists Survey demonstrates Potential for Crosspollination between Basic Scientists and MDS

    B. Bergmans, H. Tibar, M. Carecchio, S. Ibrahim El-Jafaary, M. Matarazzo, S. Perez-Lloret, R. Rajan, T. Cardoso Vale, N. Vijaratnam, T. Riestra, M. Fabbri, B. Bloem (Bruges & Ghent, Belgium)

    Objective: The purpose of the survey was to paint a clearer picture of the expectations of basic scientists on how the MDS can strengthen interactions…
  • MDS Virtual Congress 2021

    Racial and ethnic differences in patients with Parkinson’s Disease across Parkinson’s Disease Centers of Excellence

    D. Di Luca, S. Luo, T. Davis, A. Ramirez-Zamora, M. Rafferty, N. Dahodwala, C. Marras (Toronto, Canada)

    Objective: To investigate treatment, health-related quality of life, and other outcome differences in patients with Parkinson’s Disease (PD) across race and ethnicity. Background: The inclusion…
  • MDS Virtual Congress 2021

    Morbidity and mortality from neurodegenerative patients hospitalized with COVID-19 in the Chicagoland area

    R. Patel, G. Stebbins, B. Barton (Chicago, USA)

    Objective: To assess morbidity and mortality of acute COVID-19 infection in hospitalized patients with neurodegenerative diseases and compare with age-matched controls. Background: Outcomes from COVID-19…
  • MDS Virtual Congress 2021

    Significant increase of new pediatric functional movement disorders during the COVID-19 global pandemic

    K. Mackenzie, J. O'Malley (Palo Alto, USA)

    Objective: This study aims to assess the incidence of pediatric Functional Movement Disorders (FMD) during the COVID-19 global pandemic compared to pre-pandemic baseline. Background: Referrals…
  • MDS Virtual Congress 2021

    Automatic and objective speech analysis in Huntington disease

    J. Adams, E. Dorsey, M. Coffey, M. Pawlik, C. Tarolli, R. Schneider, B. Najafi, H. Zhou, A. Vaziri, H. Nguyen (Rochester, USA)

    Objective: To investigate the use of digital technology to assess speech in people with Huntington disease (HD). Background: Dysarthria is common in Huntington disease and…
  • MDS Virtual Congress 2021

    Fine-grained prediction of Huntington’s disease stage using a meta-model approach

    M. Kohli, S. Gregory, R. Scahill, S. Tabrizi, D. Alexander, P. Wijeratne (London, United Kingdom)

    Objective: We developed a machine learning (ML) framework that facilitates prediction of individual-level Huntington’s disease (HD) stage. The proposed meta-model approach classifies participants according to…
  • MDS Virtual Congress 2021

    Development of the Huntington’s Disease Integrated Staging System (HD-ISS)

    S. Tabrizi, S. Schobel, E. Gantman, A. Mansbach, B. Borowsky, P. Konstantinova, T. Mestre, A. Mullin, J. Panagoulias, K. Romero, C. Ross, S. Sivakumaran, E. Turner, M. Zauderer, J. Long, C. Sampaio (London, United Kingdom)

    Objective: To propose a new HD framework, referred to as the HD-ISS, that comprises an HD biological research definition and evidence-based staging centered on prognostic…
  • « Previous Page
  • 1
  • …
  • 99
  • 100
  • 101
  • 102
  • 103
  • …
  • 132
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
    • Help & Support
    • About Us
    • Cookies & Privacy
    • Wiley Job Network
    • Terms & Conditions
    • Advertisers & Agents
    Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
    Wiley